Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast Cancer

Jessica L Ritter1, Zehua Zhu2, Tran C Thai2

  • 1Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.

Cancer Research
|October 31, 2019
PubMed

Insights

Triple-negative breast cancer (TNBC) involves PTEN mutations and immune signaling issues. New findings show Rab7 phosphorylation by TBK1/IKKε limits STING degradation, enhancing immune responses in PTEN-null TNBC.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Triple-negative breast cancer (TNBC) is characterized by PTEN mutations and innate immune signaling dysregulation.
  • Rab7 is a known substrate of PTEN phosphatase activity.
  • Innate immune signaling kinases TBK1/IKKε are implicated in TNBC pathogenesis.

Purpose of the Study:

  • To investigate the role of Rab7 as a substrate for TBK1/IKKε in TNBC.
  • To elucidate the mechanism by which PTEN loss and TBK1/IKKε activation converge on Rab7.
  • To explore the implications of Rab7 phosphorylation for STING regulation and innate immune signaling in TNBC.

Main Methods:

  • Phosphoproteomic analysis using stable isotope labeling with amino acids in cell culture to identify novel TBK1/IKKε substrates.
  • Expression of phosphomimetic and kinase-resistant Rab7 mutants in PTEN-null TNBC cells.
  • Assessment of Rab7 localization, STING degradation, and innate immune signaling activation (e.g., IRF3 targets).
  • Analysis of STING expression in PTEN-null TNBC tumors and cell lines.

Main Results:

  • Rab7 was identified as a novel substrate for TBK1/IKKε at serine-72 (S72).
  • Phosphorylation of Rab7-S72 by TBK1/IKKε in PTEN-null TNBC cells led to diffuse cytosolic localization and enhanced innate immune signaling.
  • This phosphorylation event limited lysosomal-mediated STING degradation, increasing downstream IRF3 target gene production (CXCL10, CCL5, IFNβ).
  • PTEN-null TNBC tumors and cell lines exhibited higher STING levels and hyperresponsiveness to STING agonists.

Conclusions:

  • Rab7 acts as a key convergence point for PTEN loss and TBK1/IKKε activation in TNBC.
  • Rab7 phosphorylation by TBK1/IKKε regulates STING turnover, impacting innate immune signaling.
  • These findings reveal a novel cross-talk mechanism with STING recycling and suggest potential therapeutic strategies targeting STING agonism in TNBC.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.6K